Kairos Pharma, Ltd. (KAPA): Total Assets
$6.54M
As of 2025-12-31
$4.46M
As of 2026-06-30
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $6.54M | +13.4% | 2026-03-31, Balance as of period end |
| 2024-12-31 | $5.77M | +497.7% | 2026-03-31, Balance as of period end |
| 2023-12-31 | $965.0K | n/a | 2025-04-15, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Kairos Pharma, Ltd. (KAPA) | 2025-12-31 | $6.54M | +13.4% |
| Vyome Holdings, Inc (HIND) | 2025-12-31 | $6.50M | +370.3% |
| Adial Pharmaceuticals, Inc. (ADIL) | 2025-12-31 | $6.67M | +32.3% |
| GeoVax Labs, Inc. (GOVX) | 2025-12-31 | $6.34M | -22.2% |
| OS Therapies Inc (OSTX) | 2025-12-31 | $6.84M | +23.5% |
| Greenwich LifeSciences, Inc. (GLSI) | 2025-12-31 | $6.18M | +50.9% |
| Serina Therapeutics, Inc. (SER) | 2025-12-31 | $6.95M | +3.4% |
| CV Sciences, Inc. (CVSI) | 2025-12-31 | $6.96M | -12.2% |
| Cannapharmarx, Inc. (CPMD) | 2025-12-31 | $7.02M | -35.2% |
Compare KAPA, HIND, ADIL, GOVX side by side · Screen every company in Pharmaceutical Preparations ↗